Evidence for neuroprotection and remyelination using imaging techniques Evidence for neuroprotection and remyelination using imaging techniques2018-01-17T17:01:19-05:00
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis2018-01-17T17:01:19-05:00
Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis2018-01-17T17:01:13-05:00
Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients2018-01-17T17:01:07-05:00
White Matter Plasticity and Enhanced Remyelination in the Maternal CNS White Matter Plasticity and Enhanced Remyelination in the Maternal CNS2018-01-17T17:00:56-05:00
Heterogeneity of Multiple Sclerosis Lesions: Implications for the Pathogenesis of Demyelination Heterogeneity of Multiple Sclerosis Lesions: Implications for the Pathogenesis of Demyelination2018-01-17T17:00:56-05:00
Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology2018-01-17T17:00:50-05:00
Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment2018-01-17T17:00:50-05:00
Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+T Cells in Multiple Sclerosis Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+T Cells in Multiple Sclerosis2018-01-17T17:00:33-05:00
Development of biomarkers in multiple sclerosis Development of biomarkers in multiple sclerosis2018-01-17T17:00:33-05:00
